LISATA THERAPEUTICS, INC. Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals
LISATA THERAPEUTICS, INC. (LSTA) had Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals of $0 as of 2023-12-31, per its 10-K filed 2024-02-29.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Liabilities
us-gaap:DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals · last filed 2024-02-29
- 2023-12-31: Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals $0.00.
- 2022-12-31: Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals $99.00K.
- 2021-12-31: Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals $0.00.
| Period end | Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals |
|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-29 |
| 2022-12-31 | $99.00K 10-K · filed 2024-02-29 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| BIOVIE INC. (BIVI) | United States | $0.012B |